Correlation Between GlaxoSmithKline PLC and Boston Partners
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Boston Partners at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Boston Partners into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Boston Partners Longshort, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Boston Partners and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Boston Partners. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Boston Partners.
Diversification Opportunities for GlaxoSmithKline PLC and Boston Partners
-0.82 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between GlaxoSmithKline and Boston is -0.82. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Boston Partners Longshort in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Boston Partners Longshort and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Boston Partners. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Boston Partners Longshort has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Boston Partners go up and down completely randomly.
Pair Corralation between GlaxoSmithKline PLC and Boston Partners
Considering the 90-day investment horizon GlaxoSmithKline PLC is expected to generate 8.69 times less return on investment than Boston Partners. In addition to that, GlaxoSmithKline PLC is 1.26 times more volatile than Boston Partners Longshort. It trades about 0.0 of its total potential returns per unit of risk. Boston Partners Longshort is currently generating about 0.04 per unit of volatility. If you would invest 1,377 in Boston Partners Longshort on August 26, 2024 and sell it today you would earn a total of 177.00 from holding Boston Partners Longshort or generate 12.85% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
GlaxoSmithKline PLC ADR vs. Boston Partners Longshort
Performance |
Timeline |
GlaxoSmithKline PLC ADR |
Boston Partners Longshort |
GlaxoSmithKline PLC and Boston Partners Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with GlaxoSmithKline PLC and Boston Partners
The main advantage of trading using opposite GlaxoSmithKline PLC and Boston Partners positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Boston Partners can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Boston Partners will offset losses from the drop in Boston Partners' long position.GlaxoSmithKline PLC vs. Novartis AG ADR | GlaxoSmithKline PLC vs. AstraZeneca PLC ADR | GlaxoSmithKline PLC vs. Roche Holding Ltd | GlaxoSmithKline PLC vs. Bristol Myers Squibb |
Boston Partners vs. Aqr Managed Futures | Boston Partners vs. Neuberger Berman Long | Boston Partners vs. Asg Managed Futures | Boston Partners vs. Marketfield Fund Marketfield |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |